MedPath

Kashmari phal in excessive bleeding during menstruation

Not yet recruiting
Conditions
Excessive and frequent menstruation with regular cycle. Ayurveda Condition: ASRUGDARAH/RAKTAPRADARAH,
Registration Number
CTRI/2020/11/028989
Lead Sponsor
DrVaishali Dave
Brief Summary

Rhythm and periodicity are the characteristics of a woman’s life, so is her menstruation.Every healthy woman menstruates regularly and rhythmically every month during her reproductiveage. Any change in this normal rhythm brings curious concern to women. Dysfunctional uterinebleeding(DUB) is excessive abnormal uterine bleeding for which organic causes or pelvic pathologycannot be found.1 As we see symptoms of Asrigdara it appears analogues to DUB.

The WHO reports that 18 million women in the reproductive period suffers from DUB. Excessivemenstrual bleeding is a significant cause of morbidity during the reproductive years.2DysfunctionalUterine Bleeding has a wide spectrum of presentations that range from heavy uterinebleeding that warrant hospital admission and emergency treatment to occasional irregularuterine spotting anytime throughout the cycle. The treatment options in these conditions bymodern medicines often require a combination of invasive surgical procedures. Taking into accountthe side effects and adverse effects, The Ayurvedic management can be recommended as a safer,feasible and effective therapy for the management of heavy menstrual bleeding. The first line oftreatment for Asrukdar is Raktapittanashana Chikitsa.3Acharya charaka mentioned kashmariphalaas best Raktapitta hara and Rakta sangrahaka4. Compare to other medication kashmari phal iseasily available and cost effective. Hence Kashmari is selected as a trial drug to cure Asrukdar.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Female
Target Recruitment
5
Inclusion Criteria
  • Age 13- 45 years.
  • and willing to give their consent to participate in the study.
  • Patients with pratyatma lakshanas of asrigdara.
  • Patients diagnosed as DUB.
Exclusion Criteria
  • Patients with chronic illness.
  • Patients using intrauterine contraceptive device.
  • Patients with uterine and Pelvic pathology.
  • Benign and malignant growth.
  • Threatened , spontaneous or incomplete/ Ectopic pregnancy.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Kashmari phal will be effective in controlling excessive bleeding during menstruation4 week , then 8th week after treatment
Secondary Outcome Measures
NameTimeMethod
Reoccurrence of Condition will be preventedafter 2 months

Trial Locations

Locations (1)

JS Ayurved Mahavidyalay

🇮🇳

Kheda, GUJARAT, India

JS Ayurved Mahavidyalay
🇮🇳Kheda, GUJARAT, India
DrVaishali Dave
Principal investigator
9662140078
vaishalivasavda@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.